Singapore markets open in 1 hour 52 minutes

ZyVersa Therapeutics, Inc. (ZVSA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.8600-0.0900 (-1.82%)
At close: 04:00PM EDT
4.9900 +0.13 (+2.67%)
After hours: 06:52PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close4.9500
Open4.6200
Bid3.7600 x 200
Ask6.2200 x 200
Day's range4.5257 - 5.3000
52-week range3.9400 - 141.7500
Volume324,681
Avg. volume225,076
Market cap4.058M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    Why Is Inflammatory Disease-Focused ZyVersa Therapeutics Stock Trading Higher Today?

    ZyVersa Therapeutics Inc (NASDAQ:ZVSA) announces the publication of an article in the peer-reviewed journal Acta Neuropathologica Communications, demonstrating that inflammasome activation enhances cancer metastasis to the brain in women with triple-negative breast cancer (TNBC). Up to 40% of women with TNBC experience metastasis to their brain. Published data demonstrate that inflammasome activation increases the proliferation of TNBC cells in the brain, which was prevented by inhibition of NLR